Trial Profile
Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2020
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 11 Oct 2019 Status changed from recruiting to discontinued.
- 09 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 20 Feb 2014 New trial record